BMCM
GILD icon

Bryn Mawr Capital Management’s Gilead Sciences GILD Stock Holding History

Bryn Mawr Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$552K Sell
4,368
-118
-3% -$15.5K 0.02% 282
2026
Q1 		$625K Buy
4,486
+1,171
+35% +$164K 0.03% 253
2025
Q4 		$407K Sell
3,315
-146
-4% -$17.7K 0.02% 302
2025
Q3 		$384K Buy
3,461
+581
+20% +$66K 0.02% 311
2025
Q2 		$319K Buy
2,880
+178
+7% +$18.9K 0.02% 334
2025
Q1 		$303K Buy
2,702
+28
+1% +$2.89K 0.02% 321
2024
Q4 		$247K Sell
2,674
-26
-1% -$2.34K 0.01% 371
2024
Q3 		$226K Buy
+2,700
New +$206K 0.01% 378
2024
Q2 		– Sell
-2,800
Closed -$205K – 400
2024
Q1 		$205K Sell
2,800
-50
-2% -$3.85K 0.01% 388
2023
Q4 		$231K Buy
+2,850
New +$222K 0.01% 365

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bryn Mawr Capital Management's GILD Position: Q2 2026 in Review

Bryn Mawr Capital Management reduced its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, selling an estimated $15.5K and leaving 4,368 shares worth $552K. The position accounts for 0.02% of the portfolio, ranked #282.

Bryn Mawr Capital Management first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $625K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bryn Mawr Capital Management held 4,368 shares of Gilead Sciences worth $552K as of Q2 2026.
  • Bryn Mawr Capital Management sold 118 Gilead Sciences shares in Q2 2026, an estimated $15.5K.
  • Gilead Sciences made up 0.02% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #282 holding.
  • Bryn Mawr Capital Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • Bryn Mawr Capital Management's Gilead Sciences position peaked at $625K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.